Stay updated on Upadacitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Upadacitinib in Atopic Dermatitis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded a new publication entry for Upadacitinib efficacy in atopic dermatitis (head and neck region). Revisions indicate the current version is v3.6.3 and the older May 24, 2026 online-ahead-of-print citation (v3.6.0) was removed.SummaryDifference0.0%

- Check16 days agoChange DetectedFollowing the interim analysis, significant noncompliance was identified at a clinical site, and all data from that site (including data from 10 adolescent participants) has been excluded from the final analysis of the outcome measures as appropriate. The update also adds specific site locations (e.g., Sofia, Bulgaria; Kota Kinabalu, Sabah, Malaysia) and AbbVie’s data-sharing disclosures and related links.SummaryDifference0.5%

- Check23 days agoChange DetectedThe study is now listed as No longer looking for participants, indicating that recruitment has closed and enrollment is no longer possible. The page also adds navigation and help sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows an updated Revision: v3.6.0.SummaryDifference0.1%

- Check30 days agoChange DetectedThe revision label changed from v3.5.4 to v3.5.5, indicating a new version of the page. This reflects an update to the document, without detailing what changed.SummaryDifference0.0%

- Check38 days agoChange DetectedA new publication citation has been added to the Publications section of the study page. The entry cites Eyerich et al. on Upadacitinib efficacy in atopic dermatitis of the head and neck region (online ahead of print, 2026).SummaryDifference0.0%

- Check52 days agoChange Detected- Revision: v3.5.4 was added, replacing v3.5.3. This indicates a minor page version update with no changes to study content.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.